Concepedia

Torey Alling

TA

Statistics

Publications

16

Citations

724

H-Index

15

Active since

2013

Affiliations

Infectious Disease Research Institute(Current)

Eli Lilly (United States)

University of Notre Dame

Jubilant Life Sciences (India)

Texas A&M University

Torey Alling is an author at Infectious Disease Research Institute specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

2013–2018

16

Publications

16

A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis

Juliane Ollinger, Mai A. Bailey, Garrett C. Moraski et al. · PLoS ONE · 2013 · 177 citations · Full text

, , +16

Advancement of Imidazo[1,2-<i>a</i>]pyridines with Improved Pharmacokinetics and nM Activity vs. <i>Mycobacterium tuberculosis</i>

Garrett C. Moraski, Lowell D. Markley, Jeffrey W. Cramer et al. · ACS Medicinal Chemistry Letters · 2013 · 112 citations · Full text

, , +15

Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents

Edward A. Kesicki, Mai A. Bailey, Yulia Ovechkina et al. · PLoS ONE · 2016 · 57 citations · Full text

, , +15

Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels

Theresa O’Malley, Torey Alling, Julie V. Early et al. · Antimicrobial Agents and Chemotherapy · 2018 · 54 citations · Full text

, , +15

Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979

J. Oluoch Odingo, Theresa O’Malley, Edward A. Kesicki et al. · 2014 · 52 citations

, , +8

1–5 of 16